Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/7/2025 | $56.00 → $33.00 | Equal-Weight → Underweight | Morgan Stanley |
| 1/3/2025 | Outperform → Peer Perform | Wolfe Research | |
| 12/20/2024 | $65.00 → $57.00 | Outperform → Mkt Perform | Keefe Bruyette |
| 12/9/2024 | $60.00 → $63.00 | Overweight → Equal-Weight | Morgan Stanley |
| 9/12/2024 | $51.00 | Equal Weight | Wells Fargo |
| 1/29/2024 | $51.00 | Outperform | Keefe Bruyette |
| 1/3/2024 | $42.00 | Peer Perform → Outperform | Wolfe Research |
| 9/19/2023 | $37.00 → $32.00 | Neutral → Sell | Goldman |
SCHEDULE 13G - Lazard, Inc. (0001311370) (Subject)
8-K - Lazard, Inc. (0001311370) (Filer)
SCHEDULE 13G/A - Lazard, Inc. (0001311370) (Subject)
Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, announces the appointment of Ajay Dhankhar, PhD, as Chief Corporate Development & Strategy Officer, effective today. Ajay will report to Chief Executive Officer Deepak Nath and join the Smith+Nephew Executive Committee. As both a senior management consultant and investment banker, Ajay has advised CEOs and Boards at some of the world's leading healthcare companies, helping deliver substantial shareholder value. Ajay's experience includes 25 years with McKinsey & Company where he was a Senior Partner and held multiple leadership roles including Global Head of Strategy across all industries, Global Head of Strategy
Lazard Asset Management (LAM) today announced that Eric Van Nostrand has joined the firm as Global Head of Markets and Chief Economist. In this newly created role reporting to LAM CEO Evan Russo, Mr. Van Nostrand will work across the firm's investment and research teams, bringing additional macro insights and market perspectives to our investment decisions. As a member of the executive leadership team for Lazard's Asset Management business, he will lead economic and market analysis for the firm and its clients, including oversight and development of investment content. "Financial markets around the world are becoming increasingly complex, with global economic volatility and policy decis
Lazard, Inc. (NYSE:LAZ), the preeminent global financial advisory and asset management firm, announced today that Patrick McHenry has joined as Senior Advisor, effective April 23, 2025. McHenry brings over 20 years of experience as an elected official and leading voice on U.S. economic and financial policy. His appointment underscores Lazard's commitment to expanding its capacity to help clients navigate the increasingly complex intersection of business, politics, and global markets. "In today's evolving landscape, geopolitical dynamics and their broader implications undeniably factor into business decision-making," said Peter Orszag, CEO and Chairman of Lazard. "Patrick's deep policy expe
4 - Lazard, Inc. (0001311370) (Issuer)
4 - Lazard, Inc. (0001311370) (Issuer)
4 - Lazard, Inc. (0001311370) (Issuer)
Lazard Global Total Return and Income Fund, Inc. (the "Fund") (NYSE:LGI) is confirming today, pursuant to its Managed Distribution Policy, as previously authorized by its Board of Directors, a monthly distribution of $0.14646 per share on the Fund's outstanding common stock. The distribution is payable on July 22, 2025 to shareholders of record on July 10, 2025. The ex-dividend date is July 10, 2025. The Fund will pay a previously declared distribution today, June 24, 2025. The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid, including today's distribution, from the following sources: net investment income, net realized ca
Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, announces the appointment of Ajay Dhankhar, PhD, as Chief Corporate Development & Strategy Officer, effective today. Ajay will report to Chief Executive Officer Deepak Nath and join the Smith+Nephew Executive Committee. As both a senior management consultant and investment banker, Ajay has advised CEOs and Boards at some of the world's leading healthcare companies, helping deliver substantial shareholder value. Ajay's experience includes 25 years with McKinsey & Company where he was a Senior Partner and held multiple leadership roles including Global Head of Strategy across all industries, Global Head of Strategy
Renewables Remain Competitive, as Utility-Scale Solar and Onshore Wind Remain Most Cost-Effective Forms of New-Build Energy Generation The Tightening of Capacity Markets Has Led to a Resurgence in New-Build Gas Generation Projects, Despite Higher Levelized Costs of Energy and Commodity Price Exposure Lazard Inc. (NYSE:LAZ) is proud to announce the release of the 18th edition of its Levelized Cost of Energy+ (LCOE+) report, a widely-cited, annual analysis that provides insights into the cost competitiveness of various energy generation technologies. The report explores key aspects of energy generation, energy storage, and system-level considerations while reflecting on developments over